Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. We
estimated the global prevalence, incidence, progression, and outcomes of NAFLD and …

As the epidemics of obesity and type 2 diabetes mellitus increase worldwide, the prevalence
of non-alcoholic fatty liver disease (NAFLD) is increasing proportionately. The subtype of …

Background & Aims Nonalcoholic steatohepatitis (NASH) has been predicted to become the
leading indication for liver transplantation (LT) in the United States. However, few studies …

Objective Given significant advances in treatment of viral hepatitis and the growing epidemic
of obesity, the burden of the different types of liver diseases in the USA may be changing. …

Nonalcoholic fatty liver disease (NAFLD) is a spectrum comprised of isolated steatosis,
nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis. The majority of NAFLD …

Background & Aims: The spectrum of nonalcoholic fatty liver disease ranges from fatty liver
alone to nonalcoholic steatohepatitis. Most previous studies have short follow-up and have …

Background & Aims: This prospective study evaluates the role of radiological modalities in
establishing the diagnosis of nonalcoholic steatohepatitis (NASH). Methods: Consecutive …

… A total of 92 studies involving a total 9,361,716 of subjects (range: 102–8,120,674) were
included in the prevalence studies [subjects mean age of 48.4 years (range: 38.30–59.1 y) …

Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects
approximately one-quarter of the global adult population, causing a substantial burden of ill …

Background & Aims Although non-alcoholic fatty liver disease (NAFLD), non-alcoholic
steatohepatitis (NASH) and NASH with advanced fibrosis are closely associated with type 2 …